PBK 2 Exam 1- Bioavailability

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/29

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

30 Terms

1
New cards

Bioavailability

the rate and extent to which the active ingredient is absorbed and becomes available at the site of action

2
New cards

Bioequivalence (BE)

when pharmaceutical equivalents or pharmaceutical alternatives show no significant difference in rate and extent of absorption at the same molar dose

3
New cards

pharmaceutical equivalents

products with the same active ingredient, strength, dosage form, and route, meeting same UPS standar

4
New cards

what are pharmaceutical alternatives?

same therapeutic moiety but differ in salt/ester, dosage form, or strength; NOT interchangeable 

5
New cards

what are therapeutic equivalents?

products that are pharmaceutically equivalent and bioequivalent, producing same clinical effect and safety

6
New cards

what is the difference between BA and BE?

QBA= how much drug reaches circulation (rate and extent)

BE=compares two products BA to determine equivalence

7
New cards

Difference between pharmaceutical equivalents and alternatives?

Equivalents→ same active ingredient, dosage form, route, strength

Alternatives → same active ingredient but different in salt/ester/dosage form/strength 

8
New cards

why is bioavailability clinically important?

lower A → lower plasma concentration (Cmax) → reduced therapeutic effect and possible need for dose adjustment

9
New cards

factors that cause incomplete absorption

  • route of administration

  • physiological factors 

  • pharmaceutical factors 

10
New cards

Pharmaceutical factors that cause incomplete absorption

  • Excipients 

  • Particle size

  • Polymorphism

  • Crystalline vs amorphous 

  • Hydrate vs anhydrous form 

11
New cards

Physiological factors affecting BA

  • Gastric emptying

  • Intestinal motility

  • GI pH

  • Food/fluid intake 

  • Drug transporter 

  • First-pass metabolism 

12
New cards

What is first pass effect?

loss of drug during steps of absorption due to metabolism by the liver before reaching systemic circulation

13
New cards

What is absolute bioavailability (Fabs)?

fraction of dose reaching systemic circulation compared to IV

14
New cards

what is relative bioavailability (Frel)?

comparison of two non-IV products

does not give absolute BA

useful for generics 

15
New cards

What does the FDA require for in vivo BA studies?

BA must be measured using plasma concentration-time profiles under a controlled study protocol 

16
New cards

How do PK parameters affect the curve (Cp vs T)?

  • ↑ absorption rate → ↑  Cmax,↓ Tmax

  • ↓ absorption → ↓Cmax, ↑  Tmax

  • AUC changes only with changes in extent of absorption (F)

17
New cards

how does AUC relate to BA?

AUC reflects the extent of drug reaching systemic circulation; directly proportional to bioavailable dose

18
New cards

Which metrics measure rate of absorption?

Cmax and Tmax

19
New cards

Methods to calculate/determine AUC?

  • blood level equations

  • Trapezoidal rule (using plasma concentrations over time)

20
New cards

Can urinary excretion be used to estimate BA?

Yes. BA is proportional to the amount of unchanged drug excreted in urine

21
New cards

What are the limits of BA (AUC) calculation methods

  • blood equations require accurate PK modeling

  • trapezoidal rule requires complete sampling

  • Urinary methods are not valid if drug is heavily metabolized

22
New cards

When is AUC directly proportional to dose?

when bioavailability is independent of dose 

23
New cards

What is the general BA/BE testing procedure?

  • 12-24 healthy adults

  • overnight fasting

  • Administer the drug with water

  • collect urine/blood 

  • analyze concentration

  • plot data

24
New cards

What is 2×2 crossover design?

subjects receive both products (test &reference), separated by a washout period of ≥ 5.5-8.5 half lives, to minimize variation 

25
New cards

What is the FDA’s BE statistical requirement for BE ("80/125 rule")?

The 90% confidence interval for AUC and Cmax must fall within 80-125% of the reference 

26
New cards

What happens if AUC, Cmax, or Tmax differ significantly?

The products are not bioequivalent. Statistical analysis required if results are close

27
New cards

What does "AA" FDA code mean?

products with no known bioequivalence problems; conventional dosage forms

28
New cards

What does BX mean?

insufficient data to determine BE; not considered therapeutically equivalent

29
New cards

What does "BC" mean?

Controlled release forms with known bioequivalence issues 

30
New cards

What does "BE" mean?

Enteric coated tablets with unresolved BE issues